In conclusion, our results demonstrate that OSA inhibits RANKL-stimulated human osteoclast differentiation, gene expression of osteoclast phenotypic markers, and bone resorption. This evidence concerns the gene TNFSF11 and obstructive sleep apnea syndrome.